DarioHealth Corp. (DRIO) vs Filana Therapeutics, Inc. (FLNA)

A side-by-side comparison of DarioHealth Corp. and Filana Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DRIO vs FLNA

growth of $100 · dividends reinvested · last 1y
DRIO -47.3% (-47.3%/yr)FLNA -57.6% (-57.6%/yr)DRIO compounded faster over this window
406080100120Start $100$53$42
DRIO FLNA

DRIO vs FLNA: by the numbers

  • •DRIO is the larger company ($44M vs $41M market cap).
  • •DRIO is profitable (322.77% net margin) while FLNA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricDRIOFLNA
P/E ratio8.79N/A
P/S ratio2.11N/A
P/B ratio0.810.64

Profitability

MetricDRIOFLNA
Gross margin56.09%0.00%
Operating margin-163.94%0.00%
Net margin322.77%0.00%
ROE123.04%-66.47%
ROIC-78.42%-72.12%

Growth (annualized)

MetricDRIOFLNA
Revenue CAGR (5Y)10.10%N/A
Total return CAGR (5Y)-52.92%N/A

Frequently asked

Is DRIO or FLNA more profitable?
DRIO runs the higher net margin — DRIO at 322.77% versus FLNA at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.